Summary To study the evolution of camptothecin (CPT) resistance, we have established two small-cell lung cancer cell lines with low (3.2-fold, NYH/CAM15) and high (18-fold, NYH/CAM50) resistance to CPT by stepwise drug exposure. NYH/CAM50 cells had reduced topoisomerase (topo 1) content and activity, and consequently CPT-induced DNA single strand breaks (SSBs) were reduced, as measured by alkaline elution. In contrast, NYH/CAM15 cells had identical topo content and activity as compared with wild-type (wt) cells. CPTmediated SSBs and the rate of their reversal after drug removal were also equal in wt and NYH/CAM15 cells, as were doubling time, the fraction of cells in S-phase and DNA synthesis rate in response to CPT. As the conversion of DNA SSBs to DNA double strand breaks (DSBs) is thought to represent a critical event leading to cell death, we measured DNA DSBs by neutral elution. In contrast to DNA SSBs, CPT induced fewer DNA DSBs in NYH/CAM15 than in wt cells. DNA flow cytometry showed that, in CPT-treated cells, the G, phase was emptied as cells accumulated in late S-and G2M phase. A Spearman rank correlation showed that depletion of G1 and accumulation in late S and G2M correlated to CPT sensitivity in these three cell lines. In conclusion, acquired resistance to CPT can occur without a reduction in either topo I enzyme or CPT-induced cleavable complex formation, while a decrease in the level of CPT-induced DNA DSBs may be of major importance in the early stages of CPT resistance.
lung cancer
The camptothecins (CPTs), which poison DNA topoisomerase (topo) I, are rapidly entering clinical trials (Slichenmyer et al, 1994; Dancey and Eisenhauer, 1996) . Topo I relieves the torsional strain that accumulates as DNA replication and transcription occur. CPT stabilizes topo I-linked DNA single strand breaks (SSBs) also designated the cleavable complex (reviewed in Chen and Liu, 1994) . The formation of these DNA SSBs is a prerequisite for CPT-induced cytotoxicity. However, DNA SSBs are not by themselves sufficient to kill cells. Several studies indicate that other factors downstream from DNA SSBs are crucial to the induction of cell death, including DNA synthesis (Holm et al, 1989 ) and repair processes (Nitiss and Wang, 1988) . It has been hypothesized that the collision of cleavable complexes with advancing replication forks results in the conversion of transient DNA SSBs into the more lethal double strand breaks (DSBs) (Ryan et al, 1991) accompanied by replication fork arrest (Avemann et al, 1988) . These DNA DSBs are thought to represent a critical event in CPT cytotoxicity, as their repair is hampered by the lack of template.
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Several cell lines with acquired resistance to CPT have been characterized. To date, acquired resistance to CPT analogues has been associated with reduced formation of drug-induced DNA SSBs (reviewed . This can be due to (1) decreased enzyme levels (Eng et al, 1990) , (2) resistant forms of enzyme due to mutations (Andoh et al, 1987; Tamura et al, 1991) or (3) decreased accumulation of drug in rare cases (Chang et al, 1992) . It is still an open question whether these observations translate to the clinical situation. Thus, studies on patients with adult leukaemia failed to show any relationship between topo I levels and clinical response to topotecan (Rowinsky al, 1996) . Further, in 56 cases of lung cancer including eight patients exposed to CPT analogues, no topo I mutations were detected and the mean level of topo I mRNA was the same in those treated with or without CPT (Ohashi et al, 1996) . It therefore remains to be documented that changes in topo I parameters or topo I mutations confer clinical resistance to CPT. There are several possible explanations for these disappointing results, one being the limited clinical tumour material available, severely hampering such studies. However, one must also consider that CPT-resistant cell lines characterized to date exhibit resistance indices of 7-300, which are probably well above what will be reached in the clinical situation. To investigate the progression of CPT resistance, we have established two CPTresistant SCLC cell lines by stepwise exposure to drug: a low-level resistant line, NYH/CAM15, exhibiting 3.2-fold resistance and NYH/CAM50 with 18-fold resistance to CPT.
METHODS AND MATERIALS

Cell lines
The human SCLC cell line OC-NYH (also designated GLC-2) (de Leij et al, 1985) grows as a loosely attached monolayer in RPMI 1640 medium supplemented with 10% fetal calf serum plus penicillin, streptomycin and L-glutamine at 37°C in a humidified atmosphere with 7.5% carbon dioxide. The CPT-resistant subline NYH/CAM15 was established by exposing OC-NYH cells to increasing concentrations of drug during 9 months. Resistance was maintained by culturing cells in the presence of 15 nM CPT in every third passage. NYH/CAM50 cells were established by exposing NYH/CAM15 cells to CPT for an additional 8 months and maintained at 50 nm CPT in every third passage. Cells were grown without drug for at least two passages before experiments were performed. In order to avoid genetic drift, the cell lines used in experiments were re-established from frozen stocks at regular intervals (maximum of ten passages). Cell lines regularly tested negative for mycoplasma contamination. mitomycin C (Kyowa) were dissolved in sterile water. Vindesine (Lilly) was dissolved in isotonic sodium chloride. BCNU (BristolMyers Squibb) was dissolved in 10% (v/v) ethanol. Melphalan (Welcome) was dissolved in hydrochloric acid with ethanol and further diluted in propyleneglycol phosphate buffer. m-AMSA (Parke-Davis) delivered in N,N-dimethylacetamid solution was further diluted in acid lactose. Etoposide, teniposide, cisplatin (all from Bristol-Myers Squibb) and mitoxantrone (Lederle) were in solution for infusion. After 14-21 days, the colonies were counted. Approximately 3000-4000 colonies were obtained in the control dishes. The level of resistance was calculated as the ratio between LD ,, values (the dose reducing the number of colonies to 50% of controls) for resistant and wild-type cells. The LD 50 values used for calculating resistance indices were derived from experiments with the use of the same batch of drugs. Survival curves in Figure 1 were obtained as described above, except cells were exposed to CPT for 24 h in RPMI 1640 supplemented with 10% fetal calf serum. After drug exposure, cells were washed twice in phosphate-buffered saline (PBS) and plated as above. Approximately 10 000 colonies were obtained in the control dishes.
Clonogenic assay
Drug sensitivity was assessed by colony formation in soft agar with a feeder layer containing sheep red blood cells as previously described (Roed et al, 1987) . Sensitivity patterns depicted in Table  1 were obtained in two or three independent experiments. Solvent concentrations never exceeded 1% and had no influence on the plating efficiency. Single-cell suspensions (2 x 104 cells ml-') in RPMI 1640 supplemented with 10% fetal calf serum were plated in triplicate in the presence of drugs (continuous incubation). Fresh drug solutions were used in the clonogenic assay. CPT (Sigma), taxol (Bristol-Myers Squibb) and taxotere (Rhone-Poulenc Rohrer) were dissolved in dimethyl sulphoxide (DMSO). Topotecan (SmithKline Beecham), vincristine, gemcitabine (both from Lilly), doxorubicin, cytosine arabinoside (both from PharmaciaUpjohn), bleomycin (Lundbeck), hydroxyurea (Bristol-Myers Squibb) and I X, -i <. * (Bradford, 1976) Crude nuclear extracts Extracts were prepared as previously described with minor modifications (Deffie et al, 1989 (Bradford, 1976 (Chang et al, 1992) , or for 1 h using a polyclonal antibody against the carboxy terminus (residues 1513-30) of topo IIox (1:1000) from CRB Diagnostics (Cambridge, UK). For detection of topo I, horseradish peroxidase-linked sheep anti-mouse antibodies (Amersham, UK) were used as secondary antibodies (topo I). Membranes were incubated in a mixture of luminol and peroxide (Pierce, Rockford, IL, USA) for 5 min, with a subsequent exposure to a film. For detection of topo IIx, alkaline phosphatase-conjugated swine anti-rabbit secondary antibodies (Dako, Copenhagen, Denmark) were used. The blots were developed using Nitroblue tetrazolium and 5-bromo-4-chloro-3-indolylphosphate (both from Sigma Chemical, St Louis, MO, USA). All steps were performed at room temperature. Quantitation of immunoreactive bands was performed by densitometric scanning. In each blot, a molecular weight standard was included.
Measurement of DNA single strand breaks (SSBs) DNA damage was quantitated by the alkaline elution filter method, as described in detail by Kohn (1991 were treated with varying doses of CPT at 37°C for 60 min.
Mixing of standard and experimental cells was performed immediately before lysis. DNA was eluted at pH 12.1 under deproteinizing conditions using a Nucleopore filter (2.0 gM pore size).
Fractions were collected at 20-min intervals for 2 h with an elution rate of 0.125 ml min-'. DNA SSB frequencies were expressed in rad-equivalents and calculated as described by Kohn et al (1981) . Flow cytometric analysis of cell cycle distribution Cells were treated at various concentrations of CPT for 24 h. Cells were harvested by trypsinization and spun down, suspended in a citrate buffer, snap frozen in liquid nitrogen and stored at -80°C until further analysis. The samples were prepared for DNA flow cytometry according to the method described by Vindelov and Christensen (1990) . Chicken red blood cells and trout red blood cells were added as internal standards. Propidium iodide-stained cells were analysed on a Becton Dickinson Facs Vantage, and deconvolution of the observed histogram was performed by maximum likelihood. The parameters estimated were the phase fractions, the DNA index and the coefficient of variation (CV). The distribution of the S-phase was fitted using second-or sixthdegree polynomials, and tertiles of the S-phase were calculated. Spearman rank correlation coefficients were calculated for cell survival ( Figure 1 ) and cell cycle distribution (Figure 8 ) in response to 24-h CPT.
Apoptosis
Cells were treated for 24 h with 1-10 ItM CPT in culture flasks at a density of approximately 1 x 106 cells ml-'. Cells were either
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Cell growth
As it is a well-known fact that CPT analogues primarily exert their cytotoxic effect during S-phase, we measured cell doubling times and cell cycle phases by flow cytometry. The wild-type and both resistant sublines grew at the same rate, as the mean cell doubling times of cells in exponential growth in two independent experiments were 19, 20 and 19 h in OC-NYH, NYH/CAM15 and NYH/CAM50 respectively (Table 2) . Cell cycle distributions, including S-phase fractions of exponentially growing cells, were also essentially the same in wild-type and NYH/CAM15 cells as seen in Table 2 . The more resistant subline NYH/CAM50 had a reduced fraction of cells in G, and a corresponding increase in the G2M phase. Thus, differences in growth kinetics apparently can not explain the observed resistance. However, it appears that both resistant cell lines have lost significant amounts of DNA during their development, as indicated by the reduction in DNA index. DNA synthesis rate and DNA elongation Incorporation of labelled thymidine over three to four doubling times revealed that DNA synthesis rates were identical in wildtype and NYH/CAM15 (not shown). DNA synthesis compared with untreated controls was inhibited equally in wild-type and NYH/CAM15 cells after 1-h CPT incubation, as seen in Table 3 . Recently, it was reported that an increased ability to complete elongation of replicating DNA after CPT treatment is correlated to intrinsic resistance to CPT in unselected colon cancer cell lines (Goldwasser et al, 1996) . However, a 1-h CPT exposure followed by drug-free culture for 1, 2, 4 (not shown) and 6 h resulted in similar rates of DNA elongation in wild-type and NYH/CAM15 cells using the alkaline elution technique on pulse-labelled cells. The faster the DNA elongation rate, the longer the DNA fragments that are produced, and thus a higher fraction of DNA will remain on the filter. As seen in Figure 2 , the DNA elongation rate in both wild-type and NYH/CAM15 cells had almost reached the level of solvent-treated controls 6 h after CPT removal. In addition it appears from Figure 2 that CPT induces similar levels of DNA SSBs in newly replicated DNA.
Drug uptake Accumulation of 5 1M [3H] CPT after a 1-h incubation period was equal in wild-type and NYH/CAM 15 cells (not shown). No
P-glycoprotein expression in Western blots using C219 antibody was detected (not shown). Thus, no evidence was found suggesting that differences in drug uptake are involved in the mechanism of resistance. Evolution of camptothecin resistance in human small-cell lung cancer 2157 
DNA damage
As the level of cleavable complex formation has been found to be correlated to cytotoxicity, we measured DNA SSBs by alkaline elution. As shown in Figure 6 , increasing concentrations of CPT induced DNA SSBs in a dose-dependent manner until a plateau was reached at a concentration of 1 ,UM. Interestingly, CPT induced equal levels of DNA SSBs in wild-type as well as in NYH/CAM15. In contrast, the level of CPT-induced DNA SSBs in NYH/CAM50 was eightfold less compared with wild-type cells.
In accordance with the observed hypersensitivity towards VP-16 in the clonogenic assay, VP-16 induced 1.6-and 2.4-fold more DNA SSBs in NYH/CAM15 and NYH/CAM50, respectively, compared with wild-type cells (not shown). We studied the kinetics of the disappearance of CPT-induced SSBs after the drug was removed. Reversal of CPT-induced DNA SSBs was almost complete within 5 min at 37°C. No breaks could be detected after 10 min without drug. In order to decrease the rate of reversal, we lowered the temperature to 10°C and found that the DNA SSBs disappeared at virtually the same rate in wild-type and NYH/CAM15 cells (not shown). These data indicate that the critical events for resistance in NYH/CAM15 cells are operating downstream from the formation of cleavable complexes. The conversion of SSBs into more stable or irrepairable double strand breaks has been proposed to represent one such critical event (Avemann et al, 1988) . We therefore measured DSBs by use of neutral (pH 9.6) elution. CPT only induces a limited amount of DSBs when cells are treated for a short period, probably because ongoing DNA synthesis is needed for the conversion of SSBs to DSBs. Accordingly, we measured DSBs after 24 h of incubation as shown in 
Cell cycle distribution
The genotoxic effects of exposure to CPT leads to the accumulation of cells in the G2M phase of the cell cycle (Tobey, 1972; Tsao et al, 1992) . Perturbations of cell cycle distributions after 24 h of CPT treatment and after an additional 24 h of drug-free culture were measured by flow cytometry. The G, phase was emptied as cells accumulated in late S-and G,M phases. As it is well known that the S-G,M transition is intrinsically unstable, the last tertiles of the S-phase and the G,M region were combined for data analysis, yielding very precise estimates. As seen in Figure 8A , NYH/ CAM50 cells had a reduced tendency to accumulate in late S-and G,M compared with wild-type cells. The NYH/CAM 15 subline had an intermediate tendency to accumulate in late S-and G,M.
After an additional 24 h of incubation in the absence of drug, cell cycle distributions also reflected the degree of resistance. At low doses, cells were partly able to leave late S-and G2M and enter G, dependent on resistance level. At high doses, cells were completely halted in late S-and G,M, except for NYH/CAM50 cells ( Figure   8B ). Accumulation in late S-and G2M (r = -0.74, P < 0.008) and depletion of G, (r = 0.92, P < 0.00 1) after 24 h of drug incubation correlated negatively to cell survival, whereas in the case of early S-phase no correlation was found. Thus, accumulation in late . This event is often associated with a down-regulation of cellular topo I protein content (Eng et al, 1990) or with mutated forms of topo I rendering the enzyme itself resistant to CPT-induced DNA damage (Andoh et al, 1987; Tamura et al, 1991) . Efforts to correlate topo I parameters to clinical resistance have not been successful (Ohashi et al, 1996; Rowinsky et al, 1996 Evolution of camptothecin resistance in human small-cell lung cancer 2159 (Fujimori et al, 1996) . As cross-resistance was seen towards UV light and cisplatin, the authors speculated that increased repair capacity was involved in the mechanism of resistance. This was confirmed by measuring the ability of cells to reactivate a UVdamaged pSV-CAT plasmid. However, repair of CPT-induced damage in genomic DNA was not measured. In the present study, we exclusively measured steady-state levels of DNA DSBs, as repair studies were not feasible because of differences in cell survival after 24 h of drug treatment followed by a 24-h incubation in drug-free medium. However, we do not find it likely that increased repair is a part of the resistant phenotype in NYH/CAM15, as both hypersensitivity and cross-resistance were seen towards alkylating drugs. In another study by Beidler et al (1996) , the classical CPT resistant phenotype, i.e reduction in CPT-induced protein-linked DNA breaks, was observed in CPTresistant human nasopharyngeal cell lines and their partial revertants. Interestingly, the levels of protein-linked DNA breaks were the same in resistant and revertant cells, despite a marked difference in sensitivity to CPT. However, resistant cells had a profound reduction in DNA DSBs measured by pulse field electrophoresis compared with partial revertants, indicating that part of the resistance mechanism in these cells operates independently of the level of cleavable complexes. Recently, Goldwasser et al (1995) found that CPT-induced cleavable complexes and not topo I levels correlated to CPT cytotoxicity in a panel of unselected colon carcinoma cell lines with intrinsic differences in CPT cytotoxicity. However, in a pair of cells with an equal level of cleavable complexes, the more resistant cell line was more efficient in elongating DNA after CPT treatment and consequently could overcome an S-phase block (Goldwasser et al, 1996) . Increased ability to elongate CPTdamaged replicons does not appear to play a role in the resistant phenotype of NYH/CAM 15 cells, as the capacity for DNA elongation was similar in response to CPT. This could reflect differences between intrinsic and acquired resistance. This study contributes to the emerging data that the level of cleavable complexes are not invariably correlated to sensitivity to CPT and that other factors, such as the level of DNA DSBs, may be of greater relevance for CPT resistance. The factors responsible for conversion of DNA SSBs to DSBs are largely unknown, but are thought to be at least partly due to the DNA replication process. Use of OC-NYH and NYH/CAM15 cells, which only differ in their conversion rate, may help to elucidate which replication components are responsible for this lethal event.
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